Mesenchymal stem cells and Interleukin-6 attenuate liver fibrosis in mice
Mesenchymal stem cells and Interleukin-6 attenuate liver fibrosis in mice
About this item
Full title
Author / Creator
Publisher
England: BioMed Central Ltd
Journal title
Language
English
Formats
Publication information
Publisher
England: BioMed Central Ltd
Subjects
More information
Scope and Contents
Contents
Mesenchymal stem cell (MSC) transplantation has emerged as a promising therapy for liver fibrosis. Issues concerning poor MSC survival and engraftment in the fibrotic liver still persist and warrant development of a strategy to increase MSC potency for liver repair. The present study was designed to examine a synergistic role for Interleukin-6 (IL-...
Alternative Titles
Full title
Mesenchymal stem cells and Interleukin-6 attenuate liver fibrosis in mice
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3636128
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3636128
Other Identifiers
ISSN
1479-5876
E-ISSN
1479-5876
DOI
10.1186/1479-5876-11-78
